value

Market Access

Capital discipline in biotech: Building enduring companies w...

Capital depends on the strength of the science, the quality of execution, and the ability to deliver on milestones as planned.

R&D

A man stood on a rock looking towards the horizon

A New Framework to Engineer Breakthrough Value for Medicines

A new white paper from Lumanity – ‘A New Framework to Engineer Breakthrough Value for Medicines: Value Inflection Points Across the Development Path’.

Digital

From pilots to impact: What it really takes to scale GenAI i...

It’s no longer about what GenAI can do. It’s about what it should do – and whether it can consistently deliver value at scale.

Digital

Balancing innovation and implementation: Embracing agentic A...

A three-stage framework guides organisations through their agentic AI journey, ensuring effective ecosystem development.

Digital

A well-kept secret: Applying IEPs to accelerate digital heal...

Akira Endo discovered mevastatin, a cholesterol-lowering breakthrough molecule in 1973.

Sales & Marketing

A five-step approach for optimising established brands' port...

Established brands represent the majority of portfolios across pharma’s global affiliates that are often neglected, with revenue and profit growth untapped.

Capital discipline in biotech: Building enduring companies w...

A New Framework to Engineer Breakthrough Value for Medicines

From pilots to impact: What it really takes to scale GenAI i...

Balancing innovation and implementation: Embracing agentic A...

A well-kept secret: Applying IEPs to accelerate digital heal...

A five-step approach for optimising established brands' port...

Avalyn seeks $300m from its IPO

Discover a new era of healthcare panel engagement: Grounded ...

value

Editor's Picks